Calculated
DCF
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
72.02美元124.63美元168.31美元
-50.6%
124.63美元Current price is 50.6% below the base model value.
DX
HealthcareMedical DevicesUnited States
DXCM.US · DexCom, Inc.
NMS · US · USD
Latest price61.57美元
30D-4.16%
Vs. base value-4.9%
Research summary
DXCM.US latest organized financial period shows revenue year-over-year comparison is not complete and net income up 45.14% year over year. Current price is about 61.57美元, while the model base case is about 64.76美元; the price is -4.9% from the base case. This summary is intended for public-information research and model review.
Key financial trend
Unit: 美元
Revenue-
Net income8.36亿美元
Free cash flow10.77亿美元
Operating cash flow14.41亿美元
Price trend
Price date: 2026/04/23 · Updated: 2026/04/25 07:54
Valuation model range
Hover each model row to inspect formulas and inputs.
Current price61.57美元
Base value64.76美元
Vs. base-4.9%
Price date2026/04/23
40.03美元64.76美元84.39美元
-4.93%
Calculated
Owner Earnings
Uses recent net income as an owner-earnings proxy and discounts scenario growth.
40.03美元64.76美元84.39美元
-4.93%
64.76美元Current price is close to the base model value.
Calculated
Reverse DCF
Solves the forward FCF growth rate implied by the current price.
---
-
6.8%当前价格隐含未来 FCF 年化增长约 6.8%。
Calculated
Earnings Power Value
Estimates earnings power value without assuming growth.
15.43美元15.43美元15.43美元
+299%
15.43美元Current price is 299.2% above the base model value.
Updated: 2026/04/25 07:54
Ad placement
Quarterly and annual financial table
Financial DetailsShowing latest 5 / 80
| Period | Type | Revenue | Net Income | Free Cash Flow | Diluted EPS |
|---|---|---|---|---|---|
| 2025/12/30 | Annual | - | 8.36亿美元 | 10.77亿美元 | 2.09 |
| 2024/12/30 | Annual | - | 5.76亿美元 | 6.31亿美元 | 1.42 |
| 2023/12/30 | Annual | - | 5.42亿美元 | 5.12亿美元 | 1.3 |
| 2022/12/30 | Annual | - | 3.41亿美元 | 3.05亿美元 | 0.82 |
| 2021/12/30 | Annual | - | 1.55亿美元 | 5,330万美元 | 1.55 |
Related stocks
View allAd placement